Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time.

Original research | 2023
Youth, Mortality, Substitution/OAT, About PWUD, Outcomes

The current study examines the differential geography of opioid overdose death (OOD) by race and time (i.e., pre-fentanyl versus fentanyl era) in St. Louis, Missouri.

Original research | 2023
Overdose, Mortality, Equity, About PWUD

The aims of the study are to review the current research on the association between access to medications for opioid use disorders (MOUD) and race, to identify gaps in research methods, and to prop

Lit review | 2023
Substitution/OAT, Equity

The present study examines the longitudinal effects of a regional patient choice reform which substantially increased availability to opioid maintenance treatment in one Swedish county, starting fr

Original research | 2023
Mortality, Policy/Regulatory, Substitution/OAT

This study seeks to understand the general adult population’s knowledge, attitudes, and stigma towards methamphetamine use and people with a history of methamphetamine use.

Original research | 2023
Stigma, Stimulants, Equity
Commentary | 2023
Hallucinogens/psychedelics, Policy/Regulatory

We aimed to assess the effect of methadone on non-opioid substance use compared to buprenorphine/naloxone (BUP/NX), to explore whether non-opioid substance use is associated with opioid use and ret

Original research | 2023

Assess the preliminary impact of Brave Technology Co-op’s overdose detection devices that have been implemented in housing, medical, social service facilities, and several private settings in North

Original research | 2023
Digital health, Overdose

We conducted a retrospective cohort study of EMS patients who survived a prior opioid overdose in 2019-2021 in King County, Washington.

Original research | 2023
Overdose, Mortality, About PWUD
Manuel | 2023
site de consommation supervisée / centre de prévention des surdoses, la politique / le cadre de réglementation, les drogues illégales
Guide or handbook | 2023
SCS/OPS, Policy/Regulatory, Illegal drugs

We evaluated the effectiveness of a Two-Eyed Seeing approach in a four-week harm reduction residential treatment programme for clients with a history of substance use disorder (SUD) and intergenera

Original research | 2023
Harm reduction, Wrap-around services, About PWUD, Indigenous

We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to medications to treat opioid use disorder (MOUD, ie, buprenorphine, met

Original research | 2023
Legal system/law enforcement, Substitution/OAT
Report | 2023
Safer supply, Outcomes, Evidence base, Stimulants

Patients in treatment with medications for opioid use disorder (MOUD) often report use of other substances in addition to opioids.

Original research | 2023
Transitions in care/treatment, About PWUD, Outcomes

The objectives were to identify sociodemographic, self-reported health and mental health, patterns of service utilization (service type and frequency of visits) among youths with different levels o

Original research | 2023
About PWUD, Youth, Mental health

In this scoping review, we synthesize the existing literature on patient transition interventions, and form an initial typology of reported strategies.

Scoping review | 2023
Transitions in care/treatment, Hospitals, Barriers and enablers, About prescribers

This meta-analysis pooled effect estimates of outcomes from placebo-controlled randomized clinical trials (RCTs) examining bupropion efficacy and safety for amphetamine-type stimulant use disorder

Lit review | 2023

Refine Your Search